ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Indication For Anticoagulant Frangmin

May 25, 2007

Antman, Clanton begin work at NCI.

December 5, 2003

NCI, NEI Announce Interest In Grants On Ocular, Melanoma

November 21, 1980

NCAB Approves Plan for National Black Leadership Initiative

October 16, 1987

Patients Advocates Develop Statement On Health Care Reform

March 12, 1993

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993